Alzamend Neuro

Newport Beach, United States

Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.

$5.0M raised

Feb 2025

Post-IPO Equity

Biotechnology Health Care Health Diagnostics Medical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Alzamend Neuro

How much funding has Alzamend Neuro raised?

Alzamend Neuro has raised $5.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2025.

Where is Alzamend Neuro headquartered?

Alzamend Neuro is headquartered in Newport Beach, United States.

What does Alzamend Neuro do?

Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.

What stage is Alzamend Neuro at?

Alzamend Neuro is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 28, 2025.

MLA

"Alzamend Neuro — Funding & Investors." VCBacked, February 28, 2025, https://www.vcbacked.co/company/alzamend-neuro. Accessed July 2, 2026.

APA

VCBacked. (2025). Alzamend Neuro — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/alzamend-neuro

Wikipedia (cite web)

{{cite web |title=Alzamend Neuro — Funding & Investors |url=https://www.vcbacked.co/company/alzamend-neuro |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 28, 2025.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K